These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21807282)

  • 1. [Fixed-dose compounds and the secondary prevention of ischemic heart disease].
    Fuster V; Sanz G
    Rev Esp Cardiol; 2011 Jul; 64 Suppl 2():3-9. PubMed ID: 21807282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A polypill strategy to improve adherence: results from the FOCUS project.
    Castellano JM; Sanz G; Peñalvo JL; Bansilal S; Fernández-Ortiz A; Alvarez L; Guzmán L; Linares JC; García F; D'Aniello F; Arnáiz JA; Varea S; Martínez F; Lorenzatti A; Imaz I; Sánchez-Gómez LM; Roncaglioni MC; Baviera M; Smith SC; Taubert K; Pocock S; Brotons C; Farkouh ME; Fuster V
    J Am Coll Cardiol; 2014 Nov 18-25; 64(20):2071-82. PubMed ID: 25193393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polypill and global cardiovascular health strategies.
    Sanz G; Fuster V
    Semin Thorac Cardiovasc Surg; 2011; 23(1):24-9. PubMed ID: 21807295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of the polypill concept and ongoing clinical trials.
    Castellano JM; Sanz G; Fuster V
    Can J Cardiol; 2014 May; 30(5):520-6. PubMed ID: 24786442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
    Noll G; Kaufmann U; Wenzel RR; Lüscher TF
    Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cardiovascular polypill in high-risk patients.
    Lafeber M; Spiering W; Singh K; Guggilla RK; Patil V; Webster R;
    Eur J Prev Cardiol; 2012 Dec; 19(6):1234-42. PubMed ID: 22019908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.
    BMJ; 1994 Jan; 308(6921):81-106. PubMed ID: 8298418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibitors post-myocardial infarction.
    Young JB
    Cardiol Clin; 1995 Aug; 13(3):379-90. PubMed ID: 7585774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A survey on cerebral infarction/transient ischemic attack inpatients compliance with secondary stroke prevention and follow-up 90 days].
    Ma RH; Wang YJ; Wang CX; Zhao XQ; Wang YL; Xu MJ; Wei M; Li Y; Zhang Z; Zhang WW; Wang L; Lin L; Li HT; Zheng T; Wang XW; Li JJ; Lü Y; Qi D
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(37):2618-22. PubMed ID: 19080709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Should individuals without evidence of coronary disease and with risk factors receive continuous treatment with aspirin? Arguments against].
    López de Sá E
    Rev Esp Cardiol; 1996 Nov; 49(11):788-92. PubMed ID: 9082487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ximelagatran on ischemic events and death in patients with atrial fibrillation after acute myocardial infarction in the efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage (ESTEEM) trial.
    Tangelder MJ; Frison L; Weaver D; Wilcox RG; Bylock A; Emanuelsson H; Held P; Oldgren J
    Am Heart J; 2008 Feb; 155(2):382-7. PubMed ID: 18215612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach.
    Zeymer U; Jünger C; Zahn R; Bauer T; Bestehorn K; Senges J; Gitt A
    Curr Med Res Opin; 2011 Aug; 27(8):1563-70. PubMed ID: 21682553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute ischemic coronary artery disease and ischemic stroke: similarities and differences.
    Fisher M; Folland E
    Am J Ther; 2008; 15(2):137-49. PubMed ID: 18356634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fixed-dose combination drug for secondary cardiovascular prevention project: improving equitable access and adherence to secondary cardiovascular prevention with a fixed-dose combination drug. Study design and objectives.
    Sanz G; Fuster V; Guzmán L; Guglietta A; Arnáiz JA; Martínez F; Sarria A; Roncaglioni MC; Taubert K
    Am Heart J; 2011 Nov; 162(5):811-817.e1. PubMed ID: 22093195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Low-dose aspirin in the long-term treatment of the patient with ischemic heart disease].
    Magnani B; Semprini F
    Cardiologia; 1994 Dec; 39(12 Suppl 1):15-21. PubMed ID: 7634259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
    Liew D; Park HJ; Ko SK
    Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug secondary prevention in postmenopausal women with ischemic heart disease.
    Zdrenghea D; Pop D; Sitar-Tăut A; Cebanu M; Zdrenghea V
    Rom J Intern Med; 2009; 47(1):41-5. PubMed ID: 19886068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.